219 related articles for article (PubMed ID: 28652170)
1. Role of the androgen receptor in urothelial cancer.
Inoue S; Mizushima T; Miyamoto H
Mol Cell Endocrinol; 2018 Apr; 465():73-81. PubMed ID: 28652170
[TBL] [Abstract][Full Text] [Related]
2. Androgen receptor activation: a prospective therapeutic target for bladder cancer?
Mizushima T; Tirador KA; Miyamoto H
Expert Opin Ther Targets; 2017 Mar; 21(3):249-257. PubMed ID: 28064545
[TBL] [Abstract][Full Text] [Related]
3. Nuclear Factor-κB Promotes Urothelial Tumorigenesis and Cancer Progression via Cooperation with Androgen Receptor Signaling.
Inoue S; Ide H; Mizushima T; Jiang G; Netto GJ; Gotoh M; Miyamoto H
Mol Cancer Ther; 2018 Jun; 17(6):1303-1314. PubMed ID: 29592878
[TBL] [Abstract][Full Text] [Related]
4. Decreased tumorigenesis and mortality from bladder cancer in mice lacking urothelial androgen receptor.
Hsu JW; Hsu I; Xu D; Miyamoto H; Liang L; Wu XR; Shyr CR; Chang C
Am J Pathol; 2013 May; 182(5):1811-20. PubMed ID: 23499463
[TBL] [Abstract][Full Text] [Related]
5. The Role of Androgens and Androgen Receptor in Human Bladder Cancer.
Martínez-Rojo E; Berumen LC; García-Alcocer G; Escobar-Cabrera J
Biomolecules; 2021 Apr; 11(4):. PubMed ID: 33919565
[TBL] [Abstract][Full Text] [Related]
6. The role of the androgen receptor in the development and progression of bladder cancer.
Li Y; Izumi K; Miyamoto H
Jpn J Clin Oncol; 2012 Jul; 42(7):569-77. PubMed ID: 22593639
[TBL] [Abstract][Full Text] [Related]
7. Constitutive β-catenin activation induces male-specific tumorigenesis in the bladder urothelium.
Lin C; Yin Y; Stemler K; Humphrey P; Kibel AS; Mysorekar IU; Ma L
Cancer Res; 2013 Oct; 73(19):5914-25. PubMed ID: 23928991
[TBL] [Abstract][Full Text] [Related]
8. ELK1 is up-regulated by androgen in bladder cancer cells and promotes tumor progression.
Kawahara T; Shareef HK; Aljarah AK; Ide H; Li Y; Kashiwagi E; Netto GJ; Zheng Y; Miyamoto H
Oncotarget; 2015 Oct; 6(30):29860-76. PubMed ID: 26342199
[TBL] [Abstract][Full Text] [Related]
9. Expression of androgen and oestrogen receptors and its prognostic significance in urothelial neoplasm of the urinary bladder.
Miyamoto H; Yao JL; Chaux A; Zheng Y; Hsu I; Izumi K; Chang C; Messing EM; Netto GJ; Yeh S
BJU Int; 2012 Jun; 109(11):1716-26. PubMed ID: 22221549
[TBL] [Abstract][Full Text] [Related]
10. Expression and significance of androgen receptor coactivators in urothelial carcinoma of the bladder.
Boorjian SA; Heemers HV; Frank I; Farmer SA; Schmidt LJ; Sebo TJ; Tindall DJ
Endocr Relat Cancer; 2009 Mar; 16(1):123-37. PubMed ID: 18845648
[TBL] [Abstract][Full Text] [Related]
11. Expression of androgen receptor in non-muscle-invasive bladder cancer predicts the preventive effect of androgen deprivation therapy on tumor recurrence.
Izumi K; Ito Y; Miyamoto H; Miyoshi Y; Ota J; Moriyama M; Murai T; Hayashi H; Inayama Y; Ohashi K; Yao M; Uemura H
Oncotarget; 2016 Mar; 7(12):14153-60. PubMed ID: 26885620
[TBL] [Abstract][Full Text] [Related]
12. Biomarkers in urothelial carcinoma of the bladder: the potential cross-talk between transforming growth factor-β1 and estrogen receptor β/androgen receptor pathways.
Xu Y; Zhang NZ; Chen J; Yuan HQ
Med Hypotheses; 2013 Jun; 80(6):716-8. PubMed ID: 23490202
[TBL] [Abstract][Full Text] [Related]
13. FOXO1 as a tumor suppressor inactivated via AR/ERβ signals in urothelial cells.
Ide H; Mizushima T; Jiang G; Goto T; Nagata Y; Teramoto Y; Inoue S; Li Y; Kashiwagi E; Baras AS; Netto GJ; Kawahara T; Miyamoto H
Endocr Relat Cancer; 2020 Apr; 27(4):231-244. PubMed ID: 32031965
[TBL] [Abstract][Full Text] [Related]
14. The Role of Androgen Receptor Signaling in Ovarian Cancer.
Mizushima T; Miyamoto H
Cells; 2019 Feb; 8(2):. PubMed ID: 30791431
[TBL] [Abstract][Full Text] [Related]
15. Androgen Receptor Signaling in Bladder Cancer.
Li P; Chen J; Miyamoto H
Cancers (Basel); 2017 Feb; 9(2):. PubMed ID: 28241422
[TBL] [Abstract][Full Text] [Related]
16. The Epidemiological, Mechanistic and Potential Clinical Role of Androgen Receptor (AR) in Urothelial Carcinoma.
Bourlon MT; Flaig TW
Curr Drug Targets; 2016; 17(2):196-205. PubMed ID: 26044568
[TBL] [Abstract][Full Text] [Related]
17. Nuclear hormone receptor signals as new therapeutic targets for urothelial carcinoma.
Miyamoto H; Zheng Y; Izumi K
Curr Cancer Drug Targets; 2012 Jan; 12(1):14-22. PubMed ID: 22111835
[TBL] [Abstract][Full Text] [Related]
18. Steroid Hormone Receptor Signals as Prognosticators for Urothelial Tumor.
Ide H; Miyamoto H
Dis Markers; 2015; 2015():840640. PubMed ID: 26770009
[TBL] [Abstract][Full Text] [Related]
19. Androgen activates β-catenin signaling in bladder cancer cells.
Li Y; Zheng Y; Izumi K; Ishiguro H; Ye B; Li F; Miyamoto H
Endocr Relat Cancer; 2013 Jun; 20(3):293-304. PubMed ID: 23447569
[TBL] [Abstract][Full Text] [Related]
20. Androgen receptor promotes the migration and invasion of upper urinary tract urothelial carcinoma cells through the upregulation of MMP-9 and COX-2.
Chen CC; Hsieh TF; Chang CH; Ma WL; Hung XF; Tsai YR; Lin MH; Zhang C; Chang C; Shyr CR
Oncol Rep; 2013 Aug; 30(2):979-85. PubMed ID: 23715826
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]